Equillium (EQ) Share-based Compensation (2018 - 2026)
Equillium (EQ) posted quarterly Share-based Compensation of $930000.0 for Q1 2026, up 49.76% year-over-year from $621000.0 in Q1 2025, and up 189.68% quarter-over-quarter from -$1.0 million in Q4 2025.
Analysis
Equillium (EQ) Share-based Compensation (2018 - 2026) Analysis & Trends
Equillium (EQ) has reported Share-based Compensation for 9 consecutive years, with $930000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 49.76% year-over-year to $930000.0; the TTM figure through Mar 2026 stood at $1.3 million (down 60.72% YoY), while the FY2025 annual figure was $7.7 million, up 105.33% from the prior year.
- Share-based Compensation advanced to $930000.0 in Q1 2026 per EQ's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $8.4 million in Q3 2025 and bottomed at -$3.7 million in Q4 2022.
- Historically, Share-based Compensation has averaged $991176.5 across 5 years, with a median of $952000.0 in 2024.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 6505.56% — and 2025, when it plunged 226.31%.
- Equillium's Share-based Compensation stood at -$3.7 million in 2022, then surged by 128.0% to $1.0 million in 2023, then retreated by 21.51% to $821000.0 in 2024, then slumped by 226.31% to -$1.0 million in 2025, then jumped by 189.68% to $930000.0 in 2026.
- Business Quant data shows EQ's Share-based Compensation at $930000.0 in Q1 2026, -$1.0 million in Q4 2025, and $8.4 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 120.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 277.20 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 137.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 86.63 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Equillium | 249.33 Mn | 249.33 Mn | - | 15.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.46 Mn |
| Mar 31, 2026 | 14.31 Mn |
| Dec 31, 2025 | 737,000.00 |
| Sep 30, 2025 | 11.28 Mn |
| Jun 30, 2025 | 9.91 Mn |
| Mar 31, 2025 | 10.16 Mn |
| Dec 31, 2024 | 821,000.00 |
| Sep 30, 2024 | 9.19 Mn |
| Jun 30, 2024 | 9.18 Mn |
| Mar 31, 2024 | 9.05 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 7.17 Mn |
| Jun 30, 2023 | 7.32 Mn |
| Mar 31, 2023 | 7.10 Mn |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 5.34 Mn |
| Jun 30, 2022 | 5.30 Mn |
| Mar 31, 2022 | 5.21 Mn |
| Dec 31, 2021 | 1.15 Mn |
| Sep 30, 2021 | 3.93 Mn |